Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.20.1
Shareholders' Deficit (Tables)
 12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Schedule of nonvested activity

Redemption Period   Redemption
Percentage
1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date.     100%
2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date.     107%
3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date.     112%
4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date.     117%
5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date.     120%
Schedule of stock option activities
   

Number of

Non-vested Shares

     Weighted Average Grant Date Fair Value  
Non-vested, December 31, 2017     -     $    
Granted     6,483,732       0.62  
Forfeited     (485,060 )     0.85  
Non-vested, December 31, 2018     5,998,672       0.61  
Granted     12,000,000       0.05  
Shares vested     (323,373 )     (0.59 )
Non-vested, December 31, 2019     17,675,299     $ 0.23  
Schedule of warrant activities
    Number of Options     Weighted Average Exercise
Price		     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value		  
Balance Outstanding, December 31, 2017     14,894,213     $ 0.32                  
Exercised     (1,757,032 )     0.12                  
Forfeited     (1,691,483 )     0.66                  
Balance Outstanding, December 31, 2018     11,445,698       0.30                  
Exercised     (3,000,000 )     0.03                  
Balance Outstanding, December 31, 2019     8,445,698     $ 0.40       6.27     $ 24,600  
Exercisable, December 31, 2019     7,653,917     $ 0.41       6.11     $ 24,600  

 

    Number of Warrants     Weighted Average Exercise
Price		     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value		  
Balance Outstanding December 31, 2018     -     $ -       -     $ -  
Granted     2,050,000       0.10                  
Cancelled     -       -                  
Balance Outstanding December 31, 2019     2,050,000     $ 0.10       4.66     $ 4,400  
Exercisable, December 31, 2019     2,050,000     $ 0.10       4.66     $ 4,400